Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Safety of OSTENIL® TENDON in the Treatment of Pain and Restricted Mobility in Tendon Disorders

NCT06681051 is registered in ClinicalTrials.gov with TRB Chemedica AG as lead sponsor.

NCT NCT06681051
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06681051 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Safety of OSTENIL® TENDON in the Treatment of Pain and Restricted Mobility in Tendon Disorders
Lead sponsor
TRB Chemedica AG
Phase
Observational
Overall status
Recruiting
Start date
November 25, 2024
Completion date
October 31, 2026
Enrollment
84 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

tendinopathy